医学
心理干预
非酒精性脂肪肝
非酒精性脂肪性肝炎
数字健康
疾病
医疗保健
梅德林
肝病
家庭医学
重症监护医学
脂肪肝
内科学
护理部
政治学
法学
经济
经济增长
作者
Jeffrey V. Lazarus,Marcela Villota-Rivas,Carolina Jiménez-González,Alvaro Santos-Laso,Paula Iruzubieta,María Teresa Arias-Loste,Lisa Rice-Duek,Simon Leigh,Christopher J Kopka,Juan Turnes,José Luis Calleja,Javier Crespo
标识
DOI:10.1016/j.cld.2023.01.021
摘要
Globally, the use of digital health interventions (DHIs) is expanding, along with growing scientific evidence of their effectiveness. Given the high and increasing prevalence of noncommunicable liver disease, we surveyed 295 physicians across Spain about their knowledge, beliefs, attitudes, practices, and access with regard to DHIs for patient care and in particular for liver diseases, including nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Physicians reported high familiarity with DHIs, although most had not recommended them in patient care. Addressing concerns, including limited available time, evidence of effectiveness, education, training, and access may contribute to an increased uptake of these technologies.
科研通智能强力驱动
Strongly Powered by AbleSci AI